| Change in adherence (e.g., missing doses) |
| Change in timing of medication relative to eating |
| Malabsorption |
| Autoimmune atrophic gastritis |
| Celiac disease |
| Diabetic gastropathy |
| Helicobacter pylori gastritis |
| Medication, new initiation |
| Androgens |
| Estrogens |
| Heroin/methadone |
| Medications that decrease absorption of levothyroxine (Table 5) |
| Medications that may alter hepatic metabolism of levothyroxine (phenobarbital, rifampin) |
| Medications that may decrease levothyroxine conversion to triiodothyronine (amiodarone, high-dose beta-adrenergic agonists, glucocorticoids) |
| Medications that may reduce serum protein binding of levothyroxine (carbamazepine [Tegretol] or phenytoin [Dilantin]) |
| Selective serotonin reuptake inhibitors or tricyclic antidepressants |
| Tamoxifen |
| Pregnancy |